Kyorin Pharmaceutical Co., Ltd.

Everything filed on one company: the documents, the statements, the register, the board, the buyback and the property table — each figure as filed, with the report it came from.

Latest values as text and table

Kyorin Pharmaceutical Co., Ltd.

Kyorin Pharmaceutical Co., Ltd. (杏林製薬株式会社, 4569), Pharmaceutical. 11 cross-shareholdings, a board of 11 and 10 largest shareholders, as filed on EDINET for the year to March 2026. EDINET filing S100YDHG, filed 2026-06-18. Source: company filings on EDINET (Financial Services Agency of Japan).

Financial summary

Five-year summary as filed, latest filing per fiscal year
Fiscal year endRevenue (¥bn)Profit (¥bn)Total assets (¥bn)EPS (¥)DPS (¥)Employees
2022-03-31105.53.9171.968.6252.002,222
2023-03-31113.34.7176.082.4452.002,138
2024-03-31119.55.5177.695.4152.002,042
2025-03-31130.19.1193.6158.1757.001,998
2026-03-31126.33.4195.560.0357.001,982

Source: company filings on EDINET (Financial Services Agency of Japan). · JSON

Cross-shareholdings

Ten largest cross-shareholdings by book value, latest annual report
Company heldSharesBook value (¥bn)% of shares outstanding
ONO PHARMACEUTICAL CO., LTD.1,812,0004.50.4
KAKEN PHARMACEUTICAL CO., LTD.852,5003.52.2
AIN HOLDINGS INC.400,0002.21.1
KISSEI PHARMACEUTICAL CO., LTD.454,0002.11.1
TOHO HOLDINGS CO.,LTD.374,9801.80.6
MEDIPAL HOLDINGS CORPORATION431,2801.30.2
Alfresa Holdings Corporation319,2720.80.2
Mizuho Financial Group, Inc.114,3560.70.0
SUZUKEN CO.,LTD.58,7310.30.1
HOKUYAKU TAKEYAMA Holdings,Inc.123,8000.10.6

% of shares outstanding: shares held ÷ (issuer's issued shares − treasury shares) × 100, both as filed, the denominator taken from the issuer's own annual securities report nearest the holding's fiscal year end

Source: company filings on EDINET (Financial Services Agency of Japan). · JSON · Markdown